Operationalizing Breast Cancer Risk: A Strategic Advantage for Imaging Providers

The adoption of breast cancer risk models, such as Tyrer-Cuzick and AI-powered tools like Mirai, has enabled imaging providers to move beyond one-size-fits-all screening. But identifying elevated risk is only step one. The real value emerges when those scores become actionable.

If risk assessments are treated as checkboxes or disconnected reports, as static data points that don’t translate into workflows, high-risk patients may be identified but not referred for follow up. Opportunities for early intervention may be missed, and the promise of personalized care lost in process gaps and incomplete follow-up.

Densitas changes that by operationalizing risk estimates. 

From Passive Data to Active Workflow

The Densitas intelliRisk platform, together with the intelliMammo platform for mammography positioning quality improvement, does more than just compute reliable breast cancer risk scores and match clinical risk profiles. It connects breast cancer risk and downstream care management.

Once a patient’s risk exceeds a defined threshold (e.g., ≥20% TC8 lifetime risk) or fits a particular clinical risk profile, intelliRisk can:

• Flag patients for referral to high-risk clinics
• Alert care coordinators with triggers for patient management workflows
• Support appropriate supplemental imaging (MRI, ultrasound, CEM)
• Flag patients for genetic counseling or surgical consultation

This isn’t theoretical. It’s what forward-thinking imaging centers using intelligent automation to align with ACR and NAPBC standards can achieve, without adding administrative burden to already stretched staff.

Why It Matters: The Clinical and Financial Stakes

Risk models are built on the premise that early identification enables targeted surveillance, prevention, and treatment. But without structured follow-through, even accurate risk predictions fail to deliver value.

Consider the case of a 38-year-old woman flagged as being at high-risk due to dense breasts and family history. With Densitas intelliRisk, you can use that risk score or her clinical risk profile to trigger interventions that are appropriate, clinically impactful, and billable:

• Same-day referral to a high-risk clinic
• Genetic testing and counseling appointments
• MRI requisitions
• Patient navigator follow-up

Health systems gain service line growth:

• Improved compliance with ACA-mandated preventive care
• Reduced downstream costs by catching cancers earlier
• Stronger patient retention through personalized, high-touch care pathways
• Supplemental imaging and genetic services

In short, smarter care leads to better clinical outcomes, more appropriate follow up protocols and the associated cost savings and service line growth.

Designed for Real-World Operations

Densitas understands that not every imaging center operates at the same scale. That’s why intelliRisk works the way your organization does, either fully integrated within your EHR environment or deployed independently for maximum flexibility, supporting:

• Automated high-risk patient identification during routine mammograms
• Point-of-care risk flagging and documentation
• Care team alerts and order set automation
• Actionable worklists for physicians, nurse navigators, and genetic counselors

The platform also supports optional risk model inputs, including image-based AI-derived short-term scores and traditional models like Tyrer-Cuzick. This allows health systems to configure referral criteria that fit their resources, population, and strategic goals, whether in a large academic hub or community-based setting.

The Bottom Line: Risk-Informed Care Needs Risk-Activated Workflows

In breast cancer screening, success is measured not just by how well you assess risk, but by what you do with it.

Densitas intelliRisk turns information actionable. It doesn’t just score risk – it structures it, operationalizes it, and integrates it into clinical and administrative systems and processes. That means:

• Fewer missed high-risk patients
• Greater compliance with ACR, MQSA, and NAPBC standards
• Stronger foundations for high-risk breast cancer clinics
• Real-world clinical and financial ROI

High-risk scores that aren’t actionable are just data at a dead end. See how to make them operational.

See intelliRisk in action, book a demo.